Your browser doesn't support javascript.
loading
Decreased memory B cell frequencies in COVID-19 delta variant vaccine breakthrough infection.
Tay, Matthew Zirui; Rouers, Angeline; Fong, Siew-Wai; Goh, Yun Shan; Chan, Yi-Hao; Chang, Zi Wei; Xu, Weili; Tan, Chee Wah; Chia, Wan Ni; Torres-Ruesta, Anthony; Amrun, Siti Naqiah; Huang, Yuling; Hor, Pei Xiang; Loh, Chiew Yee; Yeo, Nicholas Kim-Wah; Wang, Bei; Ngoh, Eve Zi Xian; Salleh, Siti Nazihah Mohd; Chavatte, Jean-Marc; Lim, Alicia Jieling; Maurer-Stroh, Sebastian; Wang, Lin-Fa; Lin, Raymond Valentine Tzer Pin; Wang, Cheng-I; Tan, Seow-Yen; Young, Barnaby Edward; Leo, Yee-Sin; Lye, David C; Renia, Laurent; Ng, Lisa Fp.
Afiliação
  • Tay MZ; A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
  • Rouers A; A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
  • Fong SW; A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
  • Goh YS; A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
  • Chan YH; A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
  • Chang ZW; A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
  • Xu W; Singapore Immunology Network, A*STAR, Singapore City, Singapore.
  • Tan CW; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore City, Singapore.
  • Chia WN; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore City, Singapore.
  • Torres-Ruesta A; A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
  • Amrun SN; A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
  • Huang Y; A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
  • Hor PX; A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
  • Loh CY; A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
  • Yeo NK; A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR), Singapore City, Singapore.
  • Wang B; Singapore Immunology Network, A*STAR, Singapore City, Singapore.
  • Ngoh EZX; Singapore Immunology Network, A*STAR, Singapore City, Singapore.
  • Salleh SNM; Singapore Immunology Network, A*STAR, Singapore City, Singapore.
  • Chavatte JM; National Centre for Infectious Diseases, Singapore City, Singapore.
  • Lim AJ; National Public Health Laboratory, National Centre for Infectious Diseases, Singapore City, Singapore.
  • Maurer-Stroh S; National Centre for Infectious Diseases, Singapore City, Singapore.
  • Wang LF; National Public Health Laboratory, National Centre for Infectious Diseases, Singapore City, Singapore.
  • Lin RVTP; Bioinformatics Institute, A*STAR, Singapore City, Singapore.
  • Wang CI; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore City, Singapore.
  • Tan SY; SingHealth Duke-NUS Global Health Institute, Singapore City, Singapore.
  • Young BE; National Centre for Infectious Diseases, Singapore City, Singapore.
  • Leo YS; National Public Health Laboratory, National Centre for Infectious Diseases, Singapore City, Singapore.
  • Lye DC; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore.
  • Renia L; Singapore Immunology Network, A*STAR, Singapore City, Singapore.
  • Ng LF; Department of Infectious Diseases, Changi General Hospital, Singapore City, Singapore.
EMBO Mol Med ; 14(3): e15227, 2022 03 07.
Article em En | MEDLINE | ID: mdl-34994081

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Revista: EMBO Mol Med Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Singapura País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Revista: EMBO Mol Med Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Singapura País de publicação: Reino Unido